Advertisement

Leucovorin Calcium Injection

[01 February 2016]

Products Affected - Description

Leucovorin Calcium Lyophilized Powder for Injection, Fresenius Kabi
500 mg vial, 1 count (NDC 63323-0711-00)
 
Leucovorin Calcium lyophilized powder for solution for injection, Sagent
50 mg, vial, 10 count (NDC 25021-0813-10)

Reason for the Shortage

  • Fresenius Kabi has leucovorin on shortage due to increase demand.
  • Teva had leucovorin on allocation due to increased demand.
  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired leucovorin calcium injection from Bedford in July 2014. West-Ward is not actively marketing leucovorin calcium injection at this time.
  • Sagent has leucovorin on shortage due to manufacturing delay.

Available Products

Leucovorin Calcium lyophilized powder for solution for injection, Fresenius Kabi
200 mg, vial, 1 count (NDC 63323-0710-50)

Leucovorin Calcium Lyophilized Powder for Injection, Sagent
100 mg vial, 10 count (NDC 25021-0814-30)
200 mg vial, 1 count (NDC 25021-0815-30)
350 mg vial, 1 count (NDC 25021-0816-30)
 
Leucovorin Calcium Lyophilized Powder for Injection, Teva
100 mg vial, 1 count (NDC 00703-5140-01)
350 mg, vial, 1 count (NDC 00703-5145-01)

Estimated Resupply Dates

  • Fresenius Kabi has leucovorin 500 mg vials available on allocation.
  • Sagent has leucovorin 50 mg vials on back order and the company estimates a release date of March 2016.

Related Shortages

Updated

February 1, January 20, 2016; December 17, November 18, September 29, August 4, July 23, June 22 and 2, April 30 and 2, March 23 and 13, February 27, January 22 and 21, 2015; December 22 and 1, November 19, October 31 and 14, September 24, August 26 and 8, July 21, June 26, May 21, 8 and 7, April 24 and 8, March 31, 24, 14 and 3, February 7, January 15, 2014; November 27, 18 and 8, September 12, August 28 and 8, July 31, June 18, May 28, April 19, March 21, February 22 and 6, January 22 and 3, 2013; December 18 and 12, November 7, October 1, August 30, July 5, June 1, May 10, April 6, March 29, February 23, January 30, 2012; November 10, September 30, August 31, July 22, June 29, May 20, April 19, March 30, February 11 and 3, January 20 and 5, 2011; December 16, November 8, October 14, September 17, August 18, July 20, June 30, 2010, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement